Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Changmao Biochemical Engineering Co. Ltd. Class H ( (HK:0954) ) has shared an update.
Changmao Biochemical Engineering Co. Ltd. held its Annual General Meeting on May 28, 2025, where all proposed resolutions were unanimously approved by shareholders. Key decisions included the approval of the company’s audited financial statements for the year ending December 31, 2024, the resignation of two non-executive directors, and the election of new directors for the ninth session of the board, effective from June 18, 2025. These resolutions reflect the company’s strategic direction and governance adjustments, potentially impacting its operational focus and leadership structure.
More about Changmao Biochemical Engineering Co. Ltd. Class H
Changmao Biochemical Engineering Co. Ltd. is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the biochemical industry, focusing on the production and distribution of biochemical products.
Average Trading Volume: 705,818
Technical Sentiment Signal: Sell
Current Market Cap: HK$148.3M
For detailed information about 0954 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue